Lataa...
EXTH-06. CD38-TARGETED THERAPY IN GLIOBLASTOMA
BACKGROUND: Glioblastoma (GBM) remains a malignancy with a dismal prognosis in spite of current optimal management, including maximal resection, radiation therapy, and alkylating chemotherapy. Relapse is inevitable with the paucity of further effective therapies. The development of novel targeted th...
Tallennettuna:
| Julkaisussa: | Neuro Oncol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216983/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.355 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|